A. Gerards

2.6k citations
29 papers · 2.0k · 1 hit paper · h-index 14

Impact in

  • Rheumatology top 0.2%
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
    • Spondyloarthritis Studies and Treatments
  • Hematology top 2%
    • Autoimmune and Inflammatory Disorders Research

Papers in

  • Rheumatology 26
    • Rheumatoid Arthritis Research and Therapies 22
    • Spondyloarthritis Studies and Treatments 6
    • Systemic Lupus Erythematosus Research 4
  • Immunology 4
    • Psoriasis: Treatment and Pathogenesis 2
Co-authors
D. van Zeben (7 shared papers)P. J. S. M. Kerstens (4 shared papers)Ben A. C. Dijkmans (4 shared papers)Cornelia F Allaart (3 shared papers)Y P M Goekoop-Ruiterman (5 shared papers)M V van Krugten (5 shared papers)Jeska K de Vries‐Bouwstra (3 shared papers)J.H.L.M. van Groenendael (2 shared papers)
Journals
Annals of the Rheumatic Diseases (16 papers)Scandinavian Journal of Rheumatology (4 papers)Arthritis Research & Therapy (3 papers)Clinical Rheumatology (1 paper)Nucleosides Nucleotides & Nucleic Acids (1 paper)
Partner nations
NetherlandsGabonUnited States

In The Last Decade

A. Gerards

28 papers receiving 1.9k citations

A. Gerards's Hit Papers

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial 2005 · 1.1k citations
1.1k0+7+14Years since publication2505007501000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

  • it has ≥500 total citations;
  • it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
  • it reaches the top citation threshold in at least one of its specific research topics.
  1. 2005 Arthritis & Rheumatism

Peers

A. Gerards
Comparison fields: 5 of 80
  • Rheumatology 1.6k
  • Hematology 355
  • Genetics 160
  • Immunology 192
  • Radiology, Nuclear Medicine and Imaging 111
Replace J.H.L.M. van Groenendael with:
J.H.L.M. van Groenendael Netherlands
J-C Becker United States
Y P M Goekoop-Ruiterman Netherlands
M. Lange United States
Yvonne Sherrer United States
John Han United States
Charles Ludivico United States
J S Smolen Austria
Leroy R. Lard Netherlands
C. Gaich United States
A. Gerards relative to J.H.L.M. van Groenendael Netherlands J.H.L.M. van Groenendael's profile →
Citations per field
00.5×1.5×
J.H.L.M. van Groenendael · 1×
Citations per year

Countries citing papers authored by A. Gerards

Since Specialization
Citations

This map shows the geographic impact of A. Gerards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Gerards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Gerards more than expected).

Fields of papers citing papers by A. Gerards

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Gerards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Gerards. The network helps show where A. Gerards may publish in the future.

Co-authors

The 25 scholars most cited alongside A. Gerards, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Gerards Line = papers co-authored together A. Gerards links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial
Arthritis & Rheumatism ·Y P M Goekoop-Ruiterman, Jeska K de Vries‐Bouwstra, Cornelia F Allaart, D. van Zeben, P. J. S. M. Kerstens, Johanna M W Hazes, A. H. Zwinderman, H. K. Ronday, K. H. Han, M L Westedt, A. Gerards, J.H.L.M. van Groenendael, Willem F. Lems, M V van Krugten, F. C. Breedveld, Ben A. C. Dijkmans
Hit paper breakdown →		20051105
2
Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis
British journal of rheumatology ·A. Gerards
2003168
3
Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial
Annals of the Rheumatic Diseases ·P.H. de Jong, Johanna M. W. Hazes, P J Barendregt, Martijn Huisman, D. van Zeben, P. A. van der Lubbe, A. Gerards, M. H. de Jager, P.B. de Sonnaville, Bernard Grillet, Jolanda J. Luime, A. Weel
201297
4
Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial
Annals of the Rheumatic Diseases ·P.H. de Jong, J. M. W. Hazes, Huub KH Han, Martijn Huisman, D. van Zeben, P. A. van der Lubbe, A. Gerards, Barbara van Schaeybroeck, P.B. de Sonnaville, M V van Krugten, J. Luime, A. Weel
201493
5
Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis
Annals of the Rheumatic Diseases ·Naomi B. Klarenbeek, Rosanne Koevoets, Désirée van der Heijde, A. Gerards, S. ten Wolde, P. J. S. M. Kerstens, T. Huizinga, Ben A. C. Dijkmans, Cornelia F Allaart
201187
6
Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial
Annals of the Rheumatic Diseases ·A. Gerards, Robert Landewé, A. Prins, GA Bruijn, (unknown), Roland Laan, B. A. C. Dijkmans
200381
7
Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score
Annals of the Rheumatic Diseases ·S M van der Kooij, Jeska K de Vries‐Bouwstra, Y P M Goekoop-Ruiterman, D. van Zeben, P. J. S. M. Kerstens, A. Gerards, J.H.L.M. van Groenendael, Johanna M. W. Hazes, FC Breedveld, C. F. Allaart, Ben A. C. Dijkmans
200771
8
Sex-specific differences and how to handle them in early psoriatic arthritis
Arthritis Research & Therapy ·Evangelia Passia, Marijn Vis, Laura C. Coates, Anushka Soni, Ilja Tchetverikov, A. Gerards, Marc R. Kok, P.A.J.M. Vos, L.-A. Korswagen, Faouzia Fodili, Y P M Goekoop-Ruiterman, J. van der Kaap, M. van Oosterhout, Jolanda J. Luime
202244
9
Absence of ultrasound inflammation in patients presenting with arthralgia rules out the development of arthritis
Arthritis Research & Therapy ·Myrthe van der Ven, M. van der Veer-Meerkerk, David F Ten Cate, N. Rasappu, Marc R. Kok, D. Csakvari, J. M. W. Hazes, A. Gerards, Jolanda J. Luime
201735
10
Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial
Annals of the Rheumatic Diseases ·T. Martijn Kuijper, Jolanda J. Luime, Pascal H P de Jong, A. Gerards, D. van Zeben, Ilja Tchetverikov, P. B. J. de Sonnaville, M V van Krugten, Bernard Grillet, Johanna M. W. Hazes, A. Weel
201629
11
Rapid radiological progression in the first year of early rheumatoid arthritis is predictive of disability and joint damage progression during 8 years of follow-up
Annals of the Rheumatic Diseases ·Maries van den Broek, Linda Dirven, Jeska K de Vries‐Bouwstra, A.J. Dehpoor, Y P M Goekoop-Ruiterman, A. Gerards, P. J. S. M. Kerstens, T. Huizinga, W.F. Lems, Cornelia F Allaart
201229
12
Lessons learned from clinical phenotypes in early psoriatic arthritis: the real-world Dutch south west Early Psoriatic ARthritis study
Scandinavian Journal of Rheumatology ·FR Kasiem, J. Luime, Marijn Vis, Marc R. Kok, Kim Wervers, A. Gerards, CWY Appels, W. van der Graaff, MJF Starmans-Kool, (unknown), JHLM van Groenendael, (unknown), JJ Veris-van Dieren, J. M. W. Hazes, Ilja Tchetverikov
202022
13
Modification of a sonographic enthesitis score to differentiate between psoriatic arthritis and young healthy volunteers
Scandinavian Journal of Rheumatology ·Kim Wervers, Marijn Vis, N. Rasappu, Myrthe van der Ven, Ilja Tchetverikov, Marc R. Kok, A. Gerards, J. M. W. Hazes, JJ Luime
201822
14
Response to glucocorticoids at 2 weeks predicts the effectiveness of DMARD induction therapy at 3 months: post hoc analyses from the tREACH study
Annals of the Rheumatic Diseases ·Pascal H P de Jong, R. A. M. Quax, Margriet Huisman, A. Gerards, Richard A. Feelders, P.B. de Sonnaville, Jolanda J. Luime, A. Weel, J. M. W. Hazes
201214
15
Can baseline ultrasound results help to predict failure to achieve DAS28 remission after 1 year of tight control treatment in early RA patients?
Arthritis Research & Therapy ·David F Ten Cate, Johannes W. G. Jacobs, W. A. A. Swen, Johanna M. W. Hazes, M. H. de Jager, N. Basoski, C.J. Haagsma, Jolanda J. Luime, A. Gerards
201812
16
Methotrexate analogues display enhanced inhibition of TNF-α production in whole blood from RA patients
Scandinavian Journal of Rheumatology ·JW van der Heijden, YG Assaraf, A. Gerards, Ruud Oerlemans, WF Lems, RJ Scheper, BAC Dijkmans, Gerrit Jansen
201312
17
Two Inhibitors of DNA‐Synthesis Lead to Inhibition of Cytokine Production via a Different Mechanism
Nucleosides Nucleotides & Nucleic Acids ·Sacha de Lathouder, A. Gerards, Ben A. C. Dijkmans, LA Aarden
200411
18
Destructive joint disease in α-mannosidosis. A case report and review of the literature
Clinical Rheumatology ·A. Gerards, W. P. C. A. Winia, J. Westerga, B.A.C. Dijkmans, R. M. van Soesbergen
20038
19
Brief Report: To squeeze or not to squeeze, that is the question! Optimizing the Disease Activity Score in 28 joints by adding the squeeze test of metatarsophalangeal joints in early rheumatoid arthritis
Arthritis & Rheumatism ·P.H. de Jong, A. Weel, Y. A. de Man, A.M. Huisman, A. Gerards, M V van Krugten, Jolanda J. Luime, Johanna M. W. Hazes
20126
20
THU0289 Burden of psoriatic arthritis in different definitions of disease activity: comparing minimal disease activity and disease activity index for psoriatic arthritis
Annals of the Rheumatic Diseases ·Kim Wervers, Marijn Vis, Ilja Tchetverikov, A. Gerards, Marc R. Kok, Cathelijne Appels, W.L. van der Graaff, J.H. van Groenendael, L.-A. Korswagen, Josien J. Veris‐van Dieren, J. M. W. Hazes, Jolanda J. Luime
20186

About A. Gerards

A. Gerards is a scholar working on Rheumatology, Immunology, Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Hematology, having authored 29 papers that have together received 2.0k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (22 papers), Spondyloarthritis Studies and Treatments (6 papers), Systemic Lupus Erythematosus Research (4 papers), Acute Lymphoblastic Leukemia research (2 papers), Psoriasis: Treatment and Pathogenesis (2 papers), Autoimmune and Inflammatory Disorders Research (2 papers), Chronic Myeloid Leukemia Treatments (1 paper) and Trypanosoma species research and implications (1 paper). The work is most often cited by research in Rheumatology (1.6k citations), Hematology (355 citations), Genetics (160 citations), Immunology (192 citations) and Radiology, Nuclear Medicine and Imaging (111 citations). A. Gerards has collaborated with scholars based in Netherlands, Gabon and United States. Frequent co-authors include D. van Zeben, P. J. S. M. Kerstens, Ben A. C. Dijkmans, Cornelia F Allaart, Y P M Goekoop-Ruiterman, M V van Krugten, Jeska K de Vries‐Bouwstra, J.H.L.M. van Groenendael, F. C. Breedveld and M L Westedt. Their work appears in journals such as Annals of the Rheumatic Diseases, Scandinavian Journal of Rheumatology, Arthritis Research & Therapy, Clinical Rheumatology and Nucleosides Nucleotides & Nucleic Acids.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.H.L.M. van GroenendaelBreakdown of academic impact, for papers by J-C BeckerBreakdown of academic impact, for papers by Y P M Goekoop-RuitermanBreakdown of academic impact, for papers by M. LangeBreakdown of academic impact, for papers by Yvonne SherrerBreakdown of academic impact, for papers by John HanBreakdown of academic impact, for papers by Charles LudivicoBreakdown of academic impact, for papers by J S SmolenBreakdown of academic impact, for papers by Leroy R. LardBreakdown of academic impact, for papers by C. Gaich